Drug Profile
GIC 1002
Alternative Names: GIC-1002; Non-H2S releasing tosylate salt - gIcare PharmaLatest Information Update: 01 Mar 2024
Price :
$50
*
At a glance
- Originator gIcare Pharma
- Class Opioid analgesics
- Mechanism of Action Opioid receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Procedural pain
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for phase-I development in Procedural pain(In volunteers) in Canada (PO, Tablet)
- 01 Dec 2014 gIcare Pharma completes a phase I trial in Healthy volunteers (NCT02276768)
- 01 Oct 2014 Phase-I clinical trials in Procedural pain (In volunteers) in Canada (PO) (NCT02276768)